- Targeted Therapy of Advanced Non-Small Cell Lung Cancer
-
Lee YG, Gil HI, Kim SJ, Lee H, Nam H, Ham SY, Kang DY
- KMID: 2554309
- Korean J Med.
- 2024 Apr;99(2):96-103.
- doi: 10.3904/kjm.2024.99.2.96
Lung cancer is the leading cause of cancer death in Republic of Korea. After their initial diagnosis, only 10-20% of patients with advanced non-small cell lung cancer (NSCLC) survive for... -
- CITED
-
- Close
- SHARE
-
- Close
- Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis
-
Jang JH, Yeo HJ, Kim T, Cho WH, Min KH, Hong SB, Baek AR, Lee HK, Kim C, Chang Y, Park HK, Oh JY, Lee HB, Bae S, Moon JY, Yoo KH, Gil HI, Jeon K, on behalf of the Korean HAP/VAP Study Group
- KMID: 2541934
- Korean J Intern Med.
- 2023 May;38(3):450-450.
- doi: 10.3904/kjim.2021.348.e1
-
- CITED
-
- Close
- SHARE
-
- Close
- Microbiologic pattern and clinical outcome of non-ICU-acquired pneumonia: Korean HAP registry analysis
-
Jang JH, Yeo HJ, Kim T, Cho WH, Min KH, Hong SB, Baek AR, Lee HK, Kim C, Chang Y, Park HK, Oh JY, Lee HB, Bae S, Moon JY, Yoo KH, Gil HI, Jeon K, on behalf of the Korean HAP/VAP Study Group
- KMID: 2531479
- Korean J Intern Med.
- 2022 Jul;37(4):800-810.
- doi: 10.3904/kjim.2021.348
Background/Aims: Most studies on hospital-acquired pneumonia (HAP) have been conducted in intensive care unit (ICU) settings. This study aimed to investigate the microbiological and clinical characteristics of non-ICU-acquired pneumonia (NIAP)... -
- CITED
-
- Close
- SHARE
-
- Close
